An AllTrials project

NCT04018755: A trial that was reported late by Lynda E Polgreen

This trial has reported, although it was 606 days late in doing so.

Full data

Full entry on ClinicalTrials.gov NCT04018755
Title Open-label Pilot Study of the Effects of Anakinra in Mucopolysaccharidosis (MPS) III
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 30, 2020
Completion date July 17, 2022
Required reporting date July 17, 2023, midnight
Actual reporting date March 14, 2025
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late 606